Centre for Lifescience Technologies
Developing medical devices and diagnostics
Our Centre for Lifescience Technologies (CLT) is based in our Edinburgh office. It aims to find and develop new medical devices and diagnostics.
Our track record
CLT was involved in the creation and sale of the commercial Optical Projection Tomography (OPT) scanner ‘OPT3001’ (www.bioptonics.com) across the globe, including the UK, USA, Canada, Japan and Sweden. To date worldwide sales equate to over £2.6 million. CLT will continue to build on the success of its devices with further investment.
News feed
MRCT have recently launched a second collaboration with the University of Bristol in the area of pain medicine.
Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis
Researchers at the Breakthrough Breast Cancer Research Unit have used OPT imaging to measure changes in tumour volume.
Barbara Saxty has co-authored a Nature Communications paper entitled An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.